Auna SA
AUNA
Positions held
Your positionsAUNA isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $377.69M | Enterprise value | $3.89B | Trailing P/E | 85.00 | Forward P/E | 4.70 |
| PEG | — | Price / book | 0.73 | Beta | 0.62 | Dividend yield | 0.00% |
| Revenue growth | 13.2% | Earnings growth | -64.0% | Gross margin | 36.9% | Operating margin | 13.1% |
| Profit margin | 0.3% | ROE | 1.6% | ROA | 5.2% | Debt / equity | 1.85 |
| Current ratio | 1.08 | Free cash flow | $314.98M | Analyst recommendation | buy | Mean target | $6.99 |
| 52w high | $6.71 | 52w low | $4.09 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | |
|---|---|---|---|---|---|
| Revenue | $1.2B | $1.2B | $1.1B | $1.1B | $1.1B |
| Op margin | 12.0% | 13.1% | 13.6% | 14.3% | 15.7% |
| Net income | $29.4M | $6.5M | -$68.4M | $48.0M | $82.0M |
| Gross margin | 35.7% | 36.6% | 37.9% | 37.5% | 39.7% |
| Gross profit | $442M | $431M | $429M | $419M | $434M |
| Operating income | $149M | $155M | $153M | $160M | $172M |
- Revenue +5% vs prior quarter ($1.2B vs $1.2B).
- Gross margin 35.7% (was 36.6% prior quarter).
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|
| Revenue | $4.4B | $4.4B | $3.9B | $2.5B | — |
| Op margin | 14.4% | 17.0% | 14.1% | 9.9% | — |
| Net income | $97.6M | $110M | -$254M | -$85.6M | — |
| Gross margin | 37.9% | 39.3% | 37.0% | 35.9% | — |
| Gross profit | $1.7B | $1.7B | $1.4B | $880M | — |
| Operating income | $631M | $746M | $546M | $243M | — |
Headlines — watch
• [WARN · fundamentals] Auna S.A. (AUNA) Q2 Earnings Miss Estimates
News
2026-09-16 · Auna to Host 2026 Investor Day on October 22, 2026
2026-08-19 · Auna SA (AUNA) (Q2 2026) Earnings Call Highlights: Revenue Climbs 9% on Volume Growth, but ...
2026-08-19 · Auna Q2 Earnings Call Highlights
2026-08-19 · Auna S.A. Q2 2026 Earnings Call Summary
2026-08-18 · Auna S.A. (AUNA) Q2 Earnings Miss Estimates
2026-08-18 · Auna Announces 2Q26 Financial Results
2026-08-14 · Cerenome (CNSY) Reports Q2 Loss, Misses Revenue Estimates
2026-08-13 · Fate Therapeutics (FATE) Reports Q2 Loss, Tops Revenue Estimates
2026-08-11 · Auna S.A. (AUNA) Expected to Beat Earnings Estimates: Should You Buy?
2026-08-10 · Surgery Partners (SGRY) Q2 Earnings and Revenues Beat Estimates
2026-08-06 · Progyny (PGNY) Q2 Earnings and Revenues Beat Estimates
2026-08-05 · Solventum (SOLV) Q2 Earnings and Revenues Top Estimates
Price (daily)
Full chart · RSI · MACD · patterns